Logo
x

Search

Subscribe Now

Dong-A ST

Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)

Dong-A ST Receives the CHMP’s Positive Opinion for Imuldosa (Biosimilar, Stelara)

  • October 22, 2024
Dong-A ST Reports the US FDA’s Approval of Imuldosa (Biosimilar, Stelara)

Dong-A ST Reports the US FDA’s Approval of Imuldosa (Biosimilar, Stelara)

  • October 14, 2024
Dong-A ST Reports P-III Study Results of Ustekinumab Biosimilar DMB-3115 for the Treatment of Chronic Plaque Psoriasis

Dong-A ST Reports P-III Study Results of Ustekinumab Biosimilar DMB-3115 for the Treatment of Chronic Plaque Psoriasis

  • January 17, 2023
Dong-A ST Signed an Exclusive License Agreement with Polifarma for NESP Biosimilar DA-3880

Dong-A ST Signed an Exclusive License Agreement with Polifarma for NESP Biosimilar DA-3880

  • November 9, 2022
Insights+ Key Biosimilars Events of July 2021

Insights+ Key Biosimilars Events of July 2021

  • August 5, 2021
Insights+ Key Biosimilars Events of July 2019

Insights+ Key Biosimilars Events of July 2019

  • August 10, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.